143 related articles for article (PubMed ID: 10718774)
1. Pharmacokinetics of bambuterol during oral administration of plain tablets and solution to healthy adults.
Rosenborg J; Larsson P; Nyberg L
Br J Clin Pharmacol; 2000 Mar; 49(3):199-206. PubMed ID: 10718774
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of bambuterol in healthy subjects.
Nyberg L; Rosenborg J; Weibull E; Jönsson S; Kennedy BM; Nilsson M
Br J Clin Pharmacol; 1998 May; 45(5):471-8. PubMed ID: 9643620
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of bambuterol during oral administration to asthmatic children.
Ahlström H; Alvero J; Alvero R; Espos R; Fajutrao L; Herrera J; Kjellman B; Kubista J; Leviste C; Meyer P; Oldaeus G; Siricururat A; Vichyanond P; Wettrell G; Wong E; Laxmyr L; Nyberg L; Olsson H; Weibull E; Rosenborg J
Br J Clin Pharmacol; 1999 Sep; 48(3):299-308. PubMed ID: 10510139
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase.
Bang U; Nyberg L; Rosenborg J; Viby-Mogensen J
Br J Clin Pharmacol; 1998 May; 45(5):479-84. PubMed ID: 9643621
[TBL] [Abstract][Full Text] [Related]
5. One-year safety study with bambuterol once daily and terbutaline three times daily in 2-12-year-old children with asthma. The Bambuterol Multicentre Study Group.
Zarkovic JP; Marenk M; Valovirta E; Kuusela AL; Sandahl G; Persson B; Olsson H
Pediatr Pulmonol; 2000 Jun; 29(6):424-9. PubMed ID: 10821722
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of bambuterol.
Sitar DS
Clin Pharmacokinet; 1996 Oct; 31(4):246-56. PubMed ID: 8896942
[TBL] [Abstract][Full Text] [Related]
7. [Study on bioequivalence of domestic bambuterol capsules and imported tablets by high performance capillary zone electrophoresis].
Shi AX; Li KX; Sun CH; Cao GY
Yao Xue Xue Bao; 2003 Dec; 38(12):942-5. PubMed ID: 15040091
[TBL] [Abstract][Full Text] [Related]
8. Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma. Bambuterol Multicentre Study Group.
Kuusela AL; Marenk M; Sandahl G; Sanderud J; Nikolajev K; Persson B
Pediatr Pulmonol; 2000 Mar; 29(3):194-201. PubMed ID: 10686040
[TBL] [Abstract][Full Text] [Related]
9. Tremor in healthy volunteers after bambuterol and terbutaline CR-tablets.
Larsén K; Schmekel B
Eur J Clin Pharmacol; 1993; 45(4):303-5. PubMed ID: 8299660
[TBL] [Abstract][Full Text] [Related]
10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
11. Clinical-pharmacokinetic aspects of prolonged effect duration as illustrated by beta2-agonists.
Rosenburg J
Eur J Clin Pharmacol; 2002 Jul; 58(4):S1-21. PubMed ID: 12214578
[TBL] [Abstract][Full Text] [Related]
12. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration.
D'Alonzo GE; Smolensky MH; Feldman S; Gnosspelius Y; Karlsson K
Chest; 1995 Feb; 107(2):406-12. PubMed ID: 7842769
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of bambuterol, a long-acting bronchodilator pro-drug of terbutaline, in young and elderly patients with asthma.
Sitar DS; Warren CP; Aoki FY
Clin Pharmacol Ther; 1992 Sep; 52(3):297-306. PubMed ID: 1526088
[TBL] [Abstract][Full Text] [Related]
14. [Bioequivalence of bambuteral and its metabolites terbutaline after oral bambuteral tablet in healthy volunteers by HPLC/MS].
Sun CH; Liu L; Yin Q
Yao Xue Xue Bao; 2001 May; 36(5):368-72. PubMed ID: 12584861
[TBL] [Abstract][Full Text] [Related]
15. Bambuterol and terbutaline in human cerebrospinal fluid and plasma.
Rosberg B; Schröder C; Nyberg L; Rosenborg J; Wirén JE
Eur J Clin Pharmacol; 1993; 45(2):147-50. PubMed ID: 8223836
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma.
Fugleholm AM; Ibsen TB; Laxmyr L; Svendsen UG
Eur Respir J; 1993 Nov; 6(10):1474-8. PubMed ID: 8112441
[TBL] [Abstract][Full Text] [Related]
17. Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice daily.
Persson G; Gnosspelius Y; Anehus S
Eur Respir J; 1988 Mar; 1(3):223-6. PubMed ID: 3384075
[TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
Bramer SL; Forbes WP
Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
[TBL] [Abstract][Full Text] [Related]
19. Bambuterol: clinical effects of three doses of bambuterol once daily in asthmatic patients.
Clemmensen IH; Pedersen BK; Ravn S; Laursen LC; Weeke B
Allergy; 1988 Nov; 43(8):573-6. PubMed ID: 3061311
[TBL] [Abstract][Full Text] [Related]
20. Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin.
Petersen LJ; Skov PS
Inflamm Res; 2003 Sep; 52(9):372-7. PubMed ID: 14504664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
